Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inflammation-related miR-155-5p as an <i>APOE</i> ε4-modulated biomarker for amyloid pathology in mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026

Same author

Factor XIII Concentrate Mitigates Hemorrhage in Pediatric Extracorporeal Membrane Oxygenation Support With Acquired Factor XIII Deficiency.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2025

Same author

Metabolic changes of human induced pluripotent stem cell-derived cardiomyocytes and teratomas after transplantation.

iScience·2024

Same author

Should discontinuity of the osteotomy site 1 year after periacetabular osteotomy be diagnosed as delayed union and not non-union?

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·2024

Same author

Use of oblique view in periacetabular osteotomy and delayed postoperative weight bearing reduce delayed union in the ischium after one year.

Scientific reports·2024

Same author

Incidence and clinical outcome of lateral femoral cutaneous nerve injury after periacetabular osteotomy.

The bone & joint journal·2024

Search research articles

Related Experiment Video

Updated: May 18, 2026

Construction of a Multilayered Mesenchymal Stem Cell Sheet with a 3D Dynamic Culture System

Construction of a Multilayered Mesenchymal Stem Cell Sheet with a 3D Dynamic Culture System

Published on: October 20, 2018

Myocardial cell sheet therapy and cardiac function.

Jun Fujita¹, Yuji Itabashi, Tomohisa Seki

¹Department of Cardiology, Keio University School of Medicine, Tokyo, Japan. jfujita@a6.keio.jp

American Journal of Physiology. Heart and Circulatory Physiology

|September 25, 2012

Summary

This summary is machine-generated.

Regenerative medicine using myocardial cell sheets (MCS) shows promise for heart failure (HF) treatment. Key challenges include graft survival and electromechanical integration for effective cardiac repair.

More Related Videos

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Related Experiment Videos

Last Updated: May 18, 2026

Construction of a Multilayered Mesenchymal Stem Cell Sheet with a 3D Dynamic Culture System

Construction of a Multilayered Mesenchymal Stem Cell Sheet with a 3D Dynamic Culture System

Published on: October 20, 2018

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Area of Science:

Regenerative medicine
Cardiovascular research
Stem cell therapy

Background:

Heart failure (HF) is a leading cause of death globally.
Current stem cell therapies for HF lack reliability.
Cell sheet technology offers a novel approach for constructing aligned graft cells.

Purpose of the Study:

To evaluate the potential of myocardial cell sheets (MCS) derived from pluripotent stem cells (PSCs) for advanced heart failure treatment.
To identify key challenges and future directions for clinical application of MCS therapy.

Main Methods:

Investigated regenerative cardiomyocytes (CMs) from PSCs for MCS construction.
Assessed functional outcomes of experimental MCS, including ventricular wall stress and paracrine effects.
Analyzed critical obstacles such as graft survival, ischemia, apoptosis, inflammation, and immune response.

Main Results:

Regenerative CMs derived from PSCs are promising for MCS construction.
Experimental MCS demonstrated reduction in ventricular wall stress and paracrine effects.
Graft survival remains the most pivotal issue, influenced by ischemia, apoptosis, inflammation, and immune response.

Conclusions:

Myocardial cell sheets (MCS) from PSC-derived CMs hold potential for heart failure treatment.
Clinical application requires overcoming challenges in graft survival, vascularization, electromechanical coupling, and innervation.
Further research is needed to resolve these difficulties for successful myocardial cell therapy in advanced HF.